Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A Sensitive and Selective Immunoassay for the Quantitation of Serum Latent Myostatin after In Vivo Administration of SRK-015, a Selective Inhibitor of Myostatin Activation.

Cote SM, Jackson J, Pirruccello-Straub M, Carven GJ, Wawersik S.

SLAS Discov. 2019 Jul 26:2472555219860779. doi: 10.1177/2472555219860779. [Epub ahead of print]

PMID:
31347449
2.

CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy.

Arbeeny CM, Ling H, Smith MM, O'Brien S, Wawersik S, Ledbetter SR, McAlexander A, Schopfer FJ, Willette RN, Jorkasky DK.

J Pharmacol Exp Ther. 2019 Jun;369(3):503-510. doi: 10.1124/jpet.118.254755. Epub 2019 Mar 20.

PMID:
30894457
3.

Blocking extracellular activation of myostatin as a strategy for treating muscle wasting.

Pirruccello-Straub M, Jackson J, Wawersik S, Webster MT, Salta L, Long K, McConaughy W, Capili A, Boston C, Carven GJ, Mahanthappa NK, Turner KJ, Donovan A.

Sci Rep. 2018 Feb 2;8(1):2292. doi: 10.1038/s41598-018-20524-9.

4.

Glomerulopathy in the KK.Cg-A(y) /J mouse reflects the pathology of diabetic nephropathy.

O'Brien SP, Smith M, Ling H, Phillips L, Weber W, Lydon J, Maloney C, Ledbetter S, Arbeeny C, Wawersik S.

J Diabetes Res. 2013;2013:498925. doi: 10.1155/2013/498925. Epub 2013 Apr 24.

5.

Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling.

Vassiliadis J, Bracken C, Matthews D, O'Brien S, Schiavi S, Wawersik S.

J Am Soc Nephrol. 2011 Aug;22(8):1453-61. doi: 10.1681/ASN.2010080878. Epub 2011 Jul 22.

6.

Induction of TRPC6 channel in acquired forms of proteinuric kidney disease.

Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, Pippin JW, Rastaldi MP, Wawersik S, Schiavi S, Henger A, Kretzler M, Shankland SJ, Reiser J.

J Am Soc Nephrol. 2007 Jan;18(1):29-36. Epub 2006 Dec 13.

7.
8.

Gene expression analysis by in situ hybridization. Radioactive probes.

Wawersik S, Epstein JA.

Methods Mol Biol. 2000;137:87-96. No abstract available.

PMID:
10948528
9.

Pax6 and the genetic control of early eye development.

Wawersik S, Purcell P, Maas RL.

Results Probl Cell Differ. 2000;31:15-36. Review. No abstract available.

PMID:
10929399
10.

Vertebrate eye development as modeled in Drosophila.

Wawersik S, Maas RL.

Hum Mol Genet. 2000 Apr 12;9(6):917-25. Review.

PMID:
10767315
11.

BMP7 acts in murine lens placode development.

Wawersik S, Purcell P, Rauchman M, Dudley AT, Robertson EJ, Maas R.

Dev Biol. 1999 Mar 1;207(1):176-88.

12.

Expression of the Kallmann syndrome gene in human fetal brain and in the manipulated chick embryo.

Lutz B, Kuratani S, Rugarli EI, Wawersik S, Wong C, Bieber FR, Ballabio A, Eichele G.

Hum Mol Genet. 1994 Oct;3(10):1717-23.

PMID:
7849694
13.

The expression pattern of the chick homeobox gene gMHox suggests a role in patterning of the limbs and face and in compartmentalization of somites.

Kuratani S, Martin JF, Wawersik S, Lilly B, Eichele G, Olson EN.

Dev Biol. 1994 Feb;161(2):357-69.

PMID:
7906232
14.

Developmental regulation of the orphan receptor COUP-TF II gene in spinal motor neurons.

Lutz B, Kuratani S, Cooney AJ, Wawersik S, Tsai SY, Eichele G, Tsai MJ.

Development. 1994 Jan;120(1):25-36.

15.

Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting.

Rugarli EI, Lutz B, Kuratani SC, Wawersik S, Borsani G, Ballabio A, Eichele G.

Nat Genet. 1993 May;4(1):19-26.

PMID:
8513320

Supplemental Content

Loading ...
Support Center